CORRECTION article

Front. Cardiovasc. Med., 26 August 2020

Sec. Cardiovascular Epidemiology and Prevention

Volume 7 - 2020 | https://doi.org/10.3389/fcvm.2020.00160

Corrigendum: The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry

  • 1. Endocrinology and Cardiometabolic Center, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

  • 2. Medical Research and Biometrics Center, National Center for Cardiovascular Diseases, Beijing, China

In the original article, there was a mistake in Figure 2 and Figure 4 as published. The contentof figure 2 and figure 4 were dislabled while the legends below were in correct position, the two figures should be swaped for their positions, the Figure 2 captioned as Comparisonabout age of onset of acute myocardial infarction in probable/definite HeFH, possibleHeFH, and non-HeFH”should be the first figure presented as follows; the Figure 4 captioned as Comparison about severe clinical manifestations among probable/definiteHeFH, possible HeFH, and non-HeFH groups.”should be the second figure presented as follows.

The corrected presentation of Figure 2 and Figure 4 appears below.

Figure 2

Figure 4

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Summary

Keywords

acute myocardial infarction, heterozygous familial hypercholesterolemia, prevalence, Chinese, clinical manifestations

Citation

Shi H-W, Yang J-G, Wang Y, Li W, Guo Y-L, Gao Y, Tang Y-D, Li J-J, Wu N-Q and Yang Y-J (2020) Corrigendum: The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry. Front. Cardiovasc. Med. 7:160. doi: 10.3389/fcvm.2020.00160

Received

18 July 2020

Accepted

28 July 2020

Published

26 August 2020

Volume

7 - 2020

Edited and reviewed by

Michael D. Shapiro, Oregon Health and Science University, United States

Updates

Copyright

*Correspondence: Na-Qiong Wu Yue-Jin Yang

This article was submitted to Cardiovascular Epidemiology and Prevention, a section of the journal Frontiers in Cardiovascular Medicine

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics